Correlation Between Evoke Pharma and Sunshine Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evoke Pharma and Sunshine Biopharma, you can compare the effects of market volatilities on Evoke Pharma and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Sunshine Biopharma.

Diversification Opportunities for Evoke Pharma and Sunshine Biopharma

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Evoke and Sunshine is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Sunshine Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Sunshine Biopharma go up and down completely randomly.

Pair Corralation between Evoke Pharma and Sunshine Biopharma

Given the investment horizon of 90 days Evoke Pharma is expected to under-perform the Sunshine Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Evoke Pharma is 1.17 times less risky than Sunshine Biopharma. The stock trades about -0.39 of its potential returns per unit of risk. The Sunshine Biopharma is currently generating about -0.19 of returns per unit of risk over similar time horizon. If you would invest  191.00  in Sunshine Biopharma on January 12, 2025 and sell it today you would lose (53.00) from holding Sunshine Biopharma or give up 27.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Evoke Pharma  vs.  Sunshine Biopharma

 Performance 
       Timeline  
Evoke Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Evoke Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in May 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Sunshine Biopharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Sunshine Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in May 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Evoke Pharma and Sunshine Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Evoke Pharma and Sunshine Biopharma

The main advantage of trading using opposite Evoke Pharma and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.
The idea behind Evoke Pharma and Sunshine Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Volatility Analysis
Get historical volatility and risk analysis based on latest market data